Dr. Smith has 25 years of experience across all phases of drug discovery and development, with an emphasis on advanced therapies. He is currently focused on developing Turnstone Biologics’ next generation TIL product for solid tumors. Prior to Turnstone, he founded the IQVIA Cell and Gene Therapy Center, helping a wide variety of companies plan and execute their cell and gene therapy programs from preclinical to the market. Dr. Smith is currently an advisor for VisiCELL Medical. He also has experience with advanced therapies and other modalities at Pfizer and successful start-ups. Dr. Smith received his Ph.D. and MBA from UCSD.